PELVIC CLINICAL TARGET VOLUME DEFINITION IN HIGH-RISK PROSTATE CANCER USING SENTINEL NODE SPECT AND 18F-FCH PET-CT

被引：0
|
作者：
Vees, H. [1 ]
Steiner, C. [2 ]
Chouiter, A. [3 ]
Dipasquale, G. [1 ]
Zilli, T. [1 ]
Wissmeyer, M. [2 ]
Ratib, O. [2 ]
Buchegger, F. [2 ]
Miralbell, R. [1 ]
机构：
[1] Hop Univ Geneve, Geneva, Switzerland
[2] Hop Univ Geneve, Nucl Med, Geneva, Switzerland
[3] Hop Univ Geneve, Radiol, Geneva, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1155
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [31] Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer
    Lin-Lin Liu
    Lei-Lei Zhu
    Zhen-Guo Lu
    Jun-Die Sun
    Jun Zhao
    Hai-Feng Wang
    Zuo-Lin Xiang
    Cancer Imaging, 23
  • [32] 18F-FCH PET/CT disease detection rate in recurrent prostate cancer in relation to PSA level and PSA kinetic indexes
    Ferrari, C.
    Asabella, A. Niccoli
    Lavelli, V.
    Di Palo, A.
    Fanelli, M.
    Merenda, N.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S328 - S328
  • [33] Determination of pelvic node status in patients with high-risk localized or locally advanced prostate cancer by [11c]choline PET-CT
    Contractor, K. B.
    Challapalli, A.
    Sharma, R.
    Kenny, L. M.
    Maher, L.
    Winkler, M.
    Hellawell, G.
    Al-Nahhas, A.
    Aboagye, E.
    Mangar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Evaluation of bone metastases in prostate cancer patients bone scan compared to 18F-FCH PET/CT - with emphasis on doubtful BS results
    Tabain, A.
    Balenovic, A.
    Rogan, S. A.
    Kovacic, K.
    Kusic, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S589 - S590
  • [35] PSMA PET-CT outperforms conventional imaging in high-risk prostate cancer
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2020, 17 (06) : 319 - 319
  • [36] Phase I Study: BAY 1075553 in Comparison with 18F-FCH PET/CT in Staging and Re-Staging of Prostate Cancer Patients
    Langsteger, W.
    Loidl, W.
    Haim, S.
    Kunit, T.
    Valencia, R.
    Lesche, R.
    Dinkelborg, L.
    Hinterdorfer, S.
    Nader, M.
    Piert, M.
    Beheshti, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S255 - S255
  • [37] Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping
    Signorelli, Mauro
    Crivellaro, Cinzia
    Buda, Alessandro
    Guerra, Luca
    Fruscio, Robert
    Elisei, Federica
    Dolci, Carlotta
    Cuzzocrea, Marco
    Milani, Rodolfo
    Messa, Cristina
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (10) : 780 - 785
  • [38] 18F-Florastamin PET/CT for the initial staging of patients with high-risk prostate cancer
    Choi, W. H.
    Boo, S.
    Choi, Y.
    Kim, H.
    Lee, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S460 - S460
  • [39] Intensity-modulated radiotherapy with sentinel-node-based target volume optimisation in "high-risk" prostate cancer
    Ganswindt, U
    Paulsen, F
    Glocker, S
    Birkner, M
    Alber, M
    Corvin, S
    Anastasiadis, A
    Eichhorn, K
    Bares, R
    Stenzl, A
    Bamberg, M
    Belka, C
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 4 - 4
  • [40] Intensity-modulated radiotherapy with sentinel-node-based target volume optimisation in "high-risk" prostate cancer - first clinical experiences
    Ganswindt, U.
    Paulsen, F.
    Alber, M.
    Corvin, S.
    Bares, R.
    Hundt, I
    Stenzl, A.
    Bamberg, M.
    Belka, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 78 - 78
12345